SMART Biotech ^{For Profit}

SMART Biotech's platform technology, Stimmunology™, enables detection of various infectious diseases (HIV, HCV and others) within days of infection by processing and enhancing the blood sample prior to testing. Their sample processing device, SMARTube™, causes the production of antibodies (in-vitro) in cases where antibodies are not produced in-vivo, thus enabling commercially available assays to detect various infections within days rather than weeks and months. The SMARTube can also be used as an effective tool to distinct between recent and non-recent infection and as a tool to inform regarding viral clearance (be it spontaneous or drug elicited) shortly after it happens.